Publications

Found 2 results
Filters: Author is Z.-C. Feng  [Clear All Filters]
2013
H. Wang, Li, P., and Feng, Z. - C., Meta-analysis demonstrates association of the TGF-β1 gene -C509T polymorphism with susceptibility to IgA nephropathy in European but not in Asian populations, vol. 12, pp. 434-442, 2013.
Awad MR, El-Gamel A, Hasleton P, Turner DM, et al. (1998). Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 66: 1014-1020. http://dx.doi.org/10.1097/00007890-199810270-00009 PMid:9808485   Baan CC, Balk AH, Holweg CT, van Riemsdijk IC, et al. (2000). Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. J. Heart Lung Transplant. 19: 866-872. http://dx.doi.org/10.1016/S1053-2498(00)00155-8   Bantis C, Heering PJ, Aker S, Klein-Vehne N, et al. (2004). Association of interleukin-10 gene G-1082A polymorphism with the progression of primary glomerulonephritis. Kidney Int. 66: 288-294. http://dx.doi.org/10.1111/j.1523-1755.2004.00730.x PMid:15200436   Bhowmik D, Sinha S, Gupt A, Tiwari SC, et al. (2011). Clinical approach to rapidly progressive renal failure. J. Assoc. Physicians India 59: 38-41. PMid:21751663   Brezzi B, Del Prete D, Lupo A, Magistroni R, et al. (2009). Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. J. Nephrol. 22: 747-759. PMid:19967654   Carturan S, Roccatello D, Menegatti E, Di Simone D, et al. (2004). Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy. J. Nephrol. 17: 786-793. PMid:15593052   Chen BP, Wei YS, Xie JS and Huang HL (2005). Transforming growth factor beta1 gene polymorphisms in ZHUANG and HAN nationality in Guangxi Province. Chin. J. Anat. 28: 379-380.   Cotton SA, Gbadegesin RA, Williams S, Brenchley PE, et al. (2002). Role of TGF-beta1 in renal parenchymal scarring following childhood urinary tract infection. Kidney Int. 61: 61-67. http://dx.doi.org/10.1046/j.1523-1755.2002.00110.x PMid:11786085   Egger M, Davey SG, Schneider M and Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. http://dx.doi.org/10.1136/bmj.315.7109.629 PMid:9310563 PMCid:2127453   Grainger DJ, Heathcote K, Chiano M, Snieder H, et al. (1999). Genetic control of the circulating concentration of transforming growth factor type beta1. Hum. Mol. Genet. 8: 93-97. http://dx.doi.org/10.1093/hmg/8.1.93 PMid:9887336   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919   Hohenstein B, Daniel C, Wittmann S and Hugo C (2008). PDE-5 inhibition impedes TSP-1 expression, TGF-beta activation and matrix accumulation in experimental glomerulonephritis. Nephrol. Dial. Transplant. 23: 3427-3436. http://dx.doi.org/10.1093/ndt/gfn319 PMid:18596129   Holla LI, Fassmann A, Benes P, Halabala T, et al. (2002). 5 polymorphisms in the transforming growth factor-β 1 gene (TGF-beta1) in adult periodontitis. J. Clin. Periodontol. 29: 336-341. http://dx.doi.org/10.1034/j.1600-051X.2002.290409.x PMid:11966931   Iwano M (2010). EMT and TGF-beta in renal fibrosis. Front Biosci. 2: 229-238. http://dx.doi.org/10.2741/s60   Julian BA, Wyatt RJ, Matousovic K, Moldoveanu Z, et al. (2007). IgA nephropathy: a clinical overview. Contrib. Nephrol. 157: 19-26. PMid:17495433   Kovacs TJ, Harris S, Vas TK, Seres I, et al. (2006). Paraoxonase gene polymorphism and serum activity in progressive IgA nephropathy. J. Nephrol. 19: 732-738. PMid:17173245   Lacha J, Hubacek JA, Potmesil P, Viklicky O, et al. (2001). TGF-beta I gene polymorphism in heart transplant recipients - effect on renal function. Ann. Transplant. 6: 39-43. PMid:11803605   Lee HS (2011). Pathogenic role of TGF-beta in the progression of podocyte diseases. Histol. Histopathol. 26: 107-116. PMid:21117032   Li SL, Lin X, Wang J, Yang F, et al. (2011). Relationship of transforming growth factorß1 gene -509C/T polymorphism with IgA nephropathy in Western Guangxi. China J. Modern Med. 21: 1607-1610.   Lim CS, Kim YS, Chae DW, Ahn C, et al. (2005). Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Clin. Nephrol. 63: 61-67. PMid:15730046   Narita I, Saito N, Goto S, Jin S, et al. (2002). Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. Kidney Int. 61: 1853-1858. http://dx.doi.org/10.1046/j.1523-1755.2002.00336.x PMid:11967037   Narita I, Goto S, Saito N, Song J, et al. (2003). Genetic polymorphism of NPHS1 modifies the clinical manifestations of Ig A nephropathy. Lab. Invest. 83: 1193-1200. http://dx.doi.org/10.1097/01.LAB.0000080600.49276.31 PMid:12920248   Petitti DB (1994). Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis. Oxford University Press, New York.   Qin W, Zhang YJ, Tan CY, Liu XR, et al. (2008). Association of TGF-β1 gene polymorphism with IgA nephropathy. West China Med. J. 23: 61-63.   Sato F, Narita I, Goto S, Kondo D, et al. (2004). Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy. Tissue Antigens 64: 35-42. http://dx.doi.org/10.1111/j.1399-0039.2004.00256.x PMid:15191521   Song JH, Lee SW, Suh JH, Kim ES, et al. (2003). The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy. Clin. Nephrol. 60: 318-326. PMid:14640237   Syrjanen J, Hurme M, Lehtimaki T, Mustonen J, et al. (2002). Polymorphism of the cytokine genes and IgA nephropathy. Kidney Int. 61: 1079-1085. http://dx.doi.org/10.1046/j.1523-1755.2002.00193.x PMid:11849463   Vuong MT, Lundberg S, Gunnarsson I, Wramner L, et al. (2009). Genetic variation in the transforming growth factor-β1 gene is associated with susceptibility to IgA nephropathy. Nephrol. Dial. Transplant. 24: 3061-3067. http://dx.doi.org/10.1093/ndt/gfp079 PMid:19258388 PMCid:2747497   Wiwanitkit V (2006). Angiotensin-converting enzyme gene polymorphism is correlated to the progression of disease in patients with IgA nephropathy: a meta-analysis. Ren. Fail. 28: 697-699. http://dx.doi.org/10.1080/08860220600925636 PMid:17162429   Xue C, Li YJ, Li CX, Du Y, et al. (2005). Relationship of TGF-β1 -509C/T polymorphism with IgA nephropathy in HAN Nationality of Chinese Population. J. Sun Yat-Sen Univ. 26: 260-263.   Yamada Y, Miyauchi A, Goto J, Takagi Y, et al. (1998). Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J. Bone Miner. Res. 13: 1569-1576. http://dx.doi.org/10.1359/jbmr.1998.13.10.1569 PMid:9783545   Yamada Y, Miyauchi A, Takagi Y, Tanaka M, et al. (2001). Association of the C-509→T polymorphism, alone of in combination with the T869→C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J. Mol. Med. 79: 149-156. http://dx.doi.org/10.1007/s001090100190 PMid:11357939   Yamamoto R, Nagasawa Y, Shoji T, Katakami N, et al. (2012). A candidate gene approach to genetic contributors to the development of IgA nephropathy. Nephrol. Dial. Transplant. 27: 1020-1030. http://dx.doi.org/10.1093/ndt/gfr369 PMid:21737517   Yokota M, Ichihara S, Lin TL, Nakashima N, et al. (2000). Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101: 2783- 2787. http://dx.doi.org/10.1161/01.CIR.101.24.2783 PMid:10859282